Literature DB >> 27453042

Reference values for left ventricular systolic synchrony according to phase analysis of ECG-gated myocardial perfusion SPECT.

Hanna Hämäläinen1, Marja Hedman1, Tiina Laitinen1, Antti Hedman2, Antti Kivelä2, Tomi Laitinen1.   

Abstract

BACKGROUND: The aim of this study was to define reference values for left ventricular systolic synchrony and for the volume parameters of the left ventricle using myocardial perfusion SPECT-derived phase analysis method.
METHODS: We evaluated data of 433 patients who underwent myocardial perfusion SPECT/CT during January 2012-February 2013 in Kuopio University Hospital. The final study population consisted of 52 patients (aged 42-84 years) who met the criteria: (1) no previously diagnosed cardiac disease, (2) normal ECG at rest, (3) no advanced coronary artery disease in CT and 4) normal myocardial perfusion in stress/rest myocardial perfusion SPECT/CT. The severity of mechanical dyssynchrony was assessed by phase analysis of gated myocardial SPECT at stress stage after pharmacological exercise and at rest using Quantitative Gated SPECT (QGS) software. Volume parameters of the left ventricle were also assessed.
RESULTS: The phase histogram bandwidth at rest was 28.0 [63.7] degrees (median [95th percentile]). The standard deviation of phase histogram at rest was 7.8 [26.5] degrees. Entropy at the rest study was 54.0 [63.7] %. All left ventricular dyssynchrony parameters were statistically significantly higher at stress compared to rest. There were no statistically significant differences in dyssynchrony values between men and women. In volume parameters, reference values in male were expectedly higher than in female. Cardiac output did not differ significantly between genders.
CONCLUSION: In subjects without signs of cardiac diseases, the left ventricular systolic function is well synchronized. Phase analysis measurement does not depend on gender, age, BMI or blood pressure, but the values of dyssynchrony parameters increase during pharmacological stress.
© 2016 Scandinavian Society of Clinical Physiology and Nuclear Medicine. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  99mTc-tetrofosmin; ECG; QGS software; gated SPECT; heart failure; left ventricular dyssynchrony; phase analysis

Mesh:

Substances:

Year:  2016        PMID: 27453042     DOI: 10.1111/cpf.12379

Source DB:  PubMed          Journal:  Clin Physiol Funct Imaging        ISSN: 1475-0961            Impact factor:   2.273


  5 in total

Review 1.  Single-photon cardiac imaging in patients with cardiac implantable electrical devices.

Authors:  Cinzia Valzania; Rachele Bonfiglioli; Francesco Fallani; Cristian Martignani; Matteo Ziacchi; Igor Diemberger; Mauro Biffi; Stefano Fanti; Nazzareno Galiè
Journal:  J Nucl Cardiol       Date:  2020-11-25       Impact factor: 5.952

2.  Comparison of diagnostic performance of four software packages for phase dyssynchrony analysis in gated myocardial perfusion SPECT.

Authors:  Koichi Okuda; Kenichi Nakajima; Shinro Matsuo; Soichiro Kashiwaya; Hiroto Yoneyama; Takayuki Shibutani; Masahisa Onoguchi; Mitsumasa Hashimoto; Seigo Kinuya
Journal:  EJNMMI Res       Date:  2017-03-23       Impact factor: 3.138

3.  Myocardial ischemia and previous infarction contribute to left ventricular dyssynchrony in patients with coronary artery disease.

Authors:  Hanna Hämäläinen; Alisa Corovai; Jussi Laitinen; Tiina M Laitinen; Marja Hedman; Antti Hedman; Antti Kivelä; Tomi P Laitinen
Journal:  J Nucl Cardiol       Date:  2020-08-31       Impact factor: 5.952

4.  Time-modified OSEM algorithm for more robust assessment of left ventricular dyssynchrony with phase analysis in ECG-gated myocardial perfusion SPECT.

Authors:  Matti J Kortelainen; Tuomas M Koivumäki; Marko J Vauhkonen; Mikko A Hakulinen
Journal:  EJNMMI Phys       Date:  2019-12-27

5.  The assessment of left ventricular mechanical dyssynchrony from gated 99mTc-tetrofosmin SPECT and gated 18F-FDG PET by QGS: a comparative study.

Authors:  Sebastian Lehner; Frank Philipp Graner; Maximilian Fischer; Harun Ilhan; Peter Bartenstein; Andrei Todica
Journal:  J Nucl Cardiol       Date:  2021-07-19       Impact factor: 3.872

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.